ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 138 filers reported holding ANI PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,434,725 | +7.9% | 145,276 | 0.0% | 0.51% | +20.0% |
Q2 2023 | $7,820,207 | -35.7% | 145,276 | -52.6% | 0.42% | -41.0% |
Q1 2023 | $12,165,322 | -8.8% | 306,277 | -7.7% | 0.72% | -13.0% |
Q4 2022 | $13,343,929 | +22.7% | 331,691 | -2.0% | 0.83% | +20.2% |
Q3 2022 | $10,876,000 | +2.7% | 338,398 | -5.2% | 0.69% | +11.9% |
Q2 2022 | $10,588,000 | +25.8% | 356,865 | +19.2% | 0.61% | +65.1% |
Q1 2022 | $8,419,000 | +104.1% | 299,493 | +234.7% | 0.37% | +156.6% |
Q4 2021 | $4,124,000 | +40.0% | 89,491 | -14.1% | 0.14% | -48.6% |
Q3 2014 | $2,945,000 | -17.9% | 104,134 | 0.0% | 0.28% | -14.5% |
Q2 2014 | $3,586,000 | +83.7% | 104,134 | +67.2% | 0.33% | +76.5% |
Q1 2014 | $1,952,000 | – | 62,277 | – | 0.19% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANGROVE PARTNERS IM, LLC | 326,778 | $20,152,000 | 2.95% |
Hawk Ridge Capital Management | 188,761 | $11,641,000 | 1.89% |
Global Alpha Capital Management Ltd. | 169,746 | $10,468,000 | 1.55% |
Mesirow Financial Investment Management, Inc. | 5,723 | $353,000 | 1.49% |
1492 Capital Management LLC | 25,093 | $1,547,000 | 1.37% |
THB ASSET MANAGEMENT | 91,018 | $5,613,000 | 1.04% |
Regent Investment Management LLC | 41,329 | $2,549,000 | 0.78% |
Phocas Financial Corp. | 101,567 | $6,263,000 | 0.75% |
INVESTMENT COUNSELORS OF MARYLAND LLC | 284,334 | $17,535,000 | 0.75% |
HUSSMAN STRATEGIC ADVISORS, INC. | 35,500 | $2,189,000 | 0.70% |